Skip to main content
NIH funding notice RFA-MH-20-201

Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional)

Closed on April 10, 2019.

Posted
January 29, 2019
Close date
April 10, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $405,623 in first-year total cost, median $202,812.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 AARR-N (53)]2

Most frequent institutions

  1. MEDICAL COLLEGE OF WISCONSIN1
  2. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
Competing awards under RFA-MH-20-201 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Continuous Traumatic Violence and the HIV Continuum of Care Outcomes Among BMSM1R21MH122010-01QUINN, KATHERINE GVOISIN, DEXTER ROMMELLMEDICAL COLLEGE OF WISCONSIN, WI$214,605ZRG1
2020Addressing violence and HIV cascade of care outcomes among transgender women1R21MH121974-01GAMAREL, KRISTI EUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$191,018ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-MH-20-201: Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional) | ScienceDex | ConductScience